Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 1
2005 1
2006 3
2007 5
2008 1
2009 2
2010 4
2011 6
2012 4
2013 6
2014 5
2015 4
2016 4
2017 3
2018 7
2019 6
2020 10
2021 8
2022 6
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
Sriwastava S, Tandon M, Podury S, Prasad A, Wen S, Guthrie G, Kakara M, Jaiswal S, Subedi R, Elkhooly M, Lisak RP. Sriwastava S, et al. Among authors: lisak rp. J Neurol. 2021 Dec;268(12):4448-4478. doi: 10.1007/s00415-021-10611-9. Epub 2021 May 19. J Neurol. 2021. PMID: 34009454 Free PMC article. Review.
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.
Rivner MH, Quarles BM, Pan JX, Yu Z, Howard JF Jr, Corse A, Dimachkie MM, Jackson C, Vu T, Small G, Lisak RP, Belsh J, Lee I, Nowak RJ, Baute V, Scelsa S, Fernandes JA, Simmons Z, Swenson A, Barohn R, Sanka RB, Gooch C, Ubogu E, Caress J, Pasnoor M, Xu H, Mei L. Rivner MH, et al. Among authors: lisak rp. Muscle Nerve. 2020 Sep;62(3):333-343. doi: 10.1002/mus.26985. Epub 2020 Jun 10. Muscle Nerve. 2020. PMID: 32483837 Free PMC article.
Farewell editorial.
Lisak RP. Lisak RP. J Neurol Sci. 2013 Jul 15;330(1-2):1. doi: 10.1016/j.jns.2013.05.007. Epub 2013 May 17. J Neurol Sci. 2013. PMID: 23684669 No abstract available.
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Howard JF Jr, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ; Zilucoplan MG Study Group; Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF Jr, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. Howard JF Jr, et al. Among authors: lisak rp. JAMA Neurol. 2020 May 1;77(5):582-592. doi: 10.1001/jamaneurol.2019.5125. JAMA Neurol. 2020. PMID: 32065623 Free PMC article. Clinical Trial.
Myasthenia gravis.
Aarli JA, Gilhus NE, Lisak RP, Mantegazza R, Suzuki S. Aarli JA, et al. Among authors: lisak rp. Autoimmune Dis. 2011;2011:697575. doi: 10.4061/2011/697575. Epub 2012 Jan 24. Autoimmune Dis. 2011. PMID: 22312479 Free PMC article. No abstract available.
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.
Myasthenia gravis.
Jani-Acsadi A, Lisak RP. Jani-Acsadi A, et al. Among authors: lisak rp. Curr Treat Options Neurol. 2010 May;12(3):231-43. doi: 10.1007/s11940-010-0070-0. Curr Treat Options Neurol. 2010. PMID: 20842584
Other demyelinating diseases.
Tselis AC, Lisak RP. Tselis AC, et al. Among authors: lisak rp. Adv Neurol. 2006;98:335-49. Adv Neurol. 2006. PMID: 16400843 Review. No abstract available.
LRP4 antibody testing in myasthenia gravis.
Racke MK, Batish SD, Lisak RP, Barohn RJ. Racke MK, et al. Among authors: lisak rp. J Neuroimmunol. 2022 Oct 15;371:577949. doi: 10.1016/j.jneuroim.2022.577949. Epub 2022 Aug 12. J Neuroimmunol. 2022. PMID: 35973344 No abstract available.
Myasthenic crisis in COVID-19.
Delly F, Syed MJ, Lisak RP, Zutshi D. Delly F, et al. Among authors: lisak rp. J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6. J Neurol Sci. 2020. PMID: 32413767 Free PMC article.
85 results